Furthermore, another study including patients with follicular lymphoma found that the vaccine isotype of the fragment crystallizable region may affect immunogenicity, as IgM-Id-KHL improved disease-free survival, whereas IgG-Id-KLH vaccination had no effect [6]. This evidence concerns the gene CD40LG and follicular lymphoma.